-transparent.png){kind=logo}
Sixteen patients in an acute blast crisis of chronic myeloid leukaemia (CML) were treated with a combination of vincristine, 6-mercaptopurine, hydroxyurea and prednisone. Only two of these patients had complete remission on this treatment, while four had partial remission. This experience, comparable to that reported by others, suggests that aggressive treatment in the terminal phase of CML is justified only as part of a prospective and well-controlled study.
Related Publications
F Cavalli, and
L Tschopp, and
P Alberto, and
G Martz
February 1987,
The Journal of the Association of Physicians of India,
F Cavalli, and
L Tschopp, and
P Alberto, and
G Martz
February 1988,
The Journal of the Association of Physicians of India,
F Cavalli, and
L Tschopp, and
P Alberto, and
G Martz
April 1976,
Scandinavian journal of haematology,
F Cavalli, and
L Tschopp, and
P Alberto, and
G Martz
July 1999,
British journal of haematology,
F Cavalli, and
L Tschopp, and
P Alberto, and
G Martz
November 1977,
British medical journal,
F Cavalli, and
L Tschopp, and
P Alberto, and
G Martz
November 1987,
The Journal of the Association of Physicians of India,
F Cavalli, and
L Tschopp, and
P Alberto, and
G Martz
January 1978,
British medical journal,
F Cavalli, and
L Tschopp, and
P Alberto, and
G Martz
November 1977,
British medical journal,
F Cavalli, and
L Tschopp, and
P Alberto, and
G Martz
July 1978,
Bollettino dell'Istituto sieroterapico milanese,
F Cavalli, and
L Tschopp, and
P Alberto, and
G Martz
November 1965,
Journal of the Indian Medical Association,
